BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) Stock Earnings & Estimates
Europe - Euronext Milan - BIT:1BMRN - US09061G1013 - Common Stock
50.7 EUR
+0.74 (+1.48%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.096B 13.52% | 2.419B 15.42% | 2.854B 17.97% | 3.235B 13.35% | 3.528B 9.06% | 3.852B 9.18% | 3.945B 2.41% | 4.076B 3.32% | 4.226B 3.68% | 4.072B -3.64% | 4.084B 0.29% | 4.142B 1.42% | |
| EBITDA YoY % growth | 166.6M 588.43% | 290.16M 74.17% | 666.468M 129.69% | 762.27M 14.37% | 1.105B 44.96% | 1.277B 15.57% | 1.141B -10.65% | 1.288B 12.88% | 1.404B 9.01% | 1.471B 4.77% | 1.477B 0.41% | N/A | |
| EBIT YoY % growth | 64.6M 177.09% | 185.774M 187.58% | 570.042M 206.85% | 697.26M 22.32% | 1.083B 55.32% | 1.311B 21.05% | 1.269B -3.20% | 1.454B 14.58% | 1.62B 11.42% | 1.531B -5.49% | 1.498B -2.16% | 1.503B 0.33% | |
| Operating Margin | 3.08% | 7.68% | 19.97% | 21.55% | 30.70% | 34.03% | 32.17% | 35.67% | 38.33% | 37.60% | 36.68% | 36.29% | |
| EPS YoY % growth | 0.29 180.56% | 0.95 227.59% | 2.21 132.63% | 3.00 35.70% | 4.51 50.26% | 5.50 22.00% | 6.95 26.36% | 7.65 10.13% | 7.72 0.87% | 7.08 -8.26% | 7.10 0.24% | 7.23 1.92% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.87 35.40% | 1.07 12.41% | 1.09 -11.10% | 1.22 861.17% | 1.29 48.44% |
| Revenue Q2Q % growth | 838.15M 12.16% | 827.99M 11.12% | 854.78M 3.56% | 905.55M 16.67% | 937.65M 11.87% |
| EBITDA Q2Q % growth | 215.12M -19.63% | 256.85M 4.43% | 286.52M -9.76% | 266.32M 2,043.08% | 282.23M 31.20% |
| EBIT Q2Q % growth | 207.79M 21.34% | 252.43M 12.75% | 263.14M -4.96% | 296.99M 736.06% | 317.81M 52.95% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.16 -129.09% | 0.38 | -0.54 | -142.18% |
| Q2 2025 Q2Q % growth | 1.23 119.64% | 0.85 | 0.38 | 44.44% |
| Q1 2025 Q2Q % growth | 0.95 106.52% | 0.72 | 0.23 | 31.48% |
| Q4 2024 Q2Q % growth | 0.64 255.56% | 0.54 | 0.10 | 18.42% |
| Q3 2024 Q2Q % growth | 0.55 161.90% | 0.53 | 0.02 | 4.22% |
| Q2 2024 Q2Q % growth | 0.56 93.10% | 0.36 | 0.20 | 57.23% |
| Q1 2024 Q2Q % growth | 0.46 70.37% | 0.35 | 0.11 | 30.72% |
| Q4 2023 Q2Q % growth | 0.18 | 0.24 | -0.06 | -24.46% |
| Q3 2023 Q2Q % growth | 0.21 625.00% | 0.24 | -0.03 | -12.05% |
| Q2 2023 Q2Q % growth | 0.29 93.33% | 0.24 | 0.05 | 22.09% |
| Q1 2023 Q2Q % growth | 0.27 50.00% | 0.18 | 0.09 | 47.54% |
| Q4 2022 Q2Q % growth | 0.00 100.00% | -0.07 | 0.07 | 100.00% |
| Q3 2022 Q2Q % growth | -0.04 80.00% | -0.01 | -0.03 | -361.36% |
| Q2 2022 Q2Q % growth | 0.15 114.29% | 0.12 | 0.03 | 29.99% |
| Q1 2022 Q2Q % growth | 0.18 100.00% | 0.18 | 0.00 | 2.52% |
| Q4 2021 Q2Q % growth | -0.32 -366.67% | -0.33 | 0.01 | 2.37% |
| Q3 2021 Q2Q % growth | -0.20 -104.99% | -0.25 | 0.05 | 20.94% |
| Q2 2021 Q2Q % growth | 0.07 450.00% | -0.12 | 0.19 | 158.23% |
| Q1 2021 Q2Q % growth | 0.09 -79.55% | -0.07 | 0.16 | 231.05% |
| Q4 2020 Q2Q % growth | 0.12 | -0.19 | 0.31 | 161.70% |
| Q3 2020 Q2Q % growth | 4.01 | 1.26 | 2.75 | 218.06% |
| Q2 2020 Q2Q % growth | -0.02 | -0.10 | 0.08 | 79.94% |
| Q1 2020 Q2Q % growth | 0.44 | 0.05 | 0.39 | 723.70% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 776.133M 4.08% | 796.24M | -20.107M | -2.53% |
| Q2 2025 Q2Q % growth | 825.41M 15.92% | 775.18M | 50.23M | 6.48% |
| Q1 2025 Q2Q % growth | 745.145M 14.84% | 755.53M | -10.385M | -1.37% |
| Q4 2024 Q2Q % growth | 747.313M 15.65% | 727.71M | 19.603M | 2.69% |
| Q3 2024 Q2Q % growth | 745.74M 28.29% | 714.18M | 31.56M | 4.42% |
| Q2 2024 Q2Q % growth | 712.029M 19.61% | 675.29M | 36.739M | 5.44% |
| Q1 2024 Q2Q % growth | 648.833M 8.79% | 664.82M | -15.987M | -2.40% |
| Q4 2023 Q2Q % growth | 646.207M 20.22% | 649.62M | -3.413M | -0.53% |
| Q3 2023 Q2Q % growth | 581.3M 15.04% | 620.85M | -39.55M | -6.37% |
| Q2 2023 Q2Q % growth | 595.3M 11.52% | 607.14M | -11.84M | -1.95% |
| Q1 2023 Q2Q % growth | 596.4M 14.82% | 582.04M | 14.36M | 2.47% |
| Q4 2022 Q2Q % growth | 537.5M 19.50% | 547.71M | -10.21M | -1.86% |
| Q3 2022 Q2Q % growth | 505.3M 23.64% | 528.78M | -23.48M | -4.44% |
| Q2 2022 Q2Q % growth | 533.8M 6.40% | 531.9M | 1.9M | 0.36% |
| Q1 2022 Q2Q % growth | 519.4M 6.87% | 517.67M | 1.73M | 0.33% |
| Q4 2021 Q2Q % growth | 449.8M -0.51% | 451.23M | -1.43M | -0.32% |
| Q3 2021 Q2Q % growth | 408.7M -14.28% | 444.03M | -35.33M | -7.96% |
| Q2 2021 Q2Q % growth | 501.7M 16.81% | 457.47M | 44.23M | 9.67% |
| Q1 2021 Q2Q % growth | 486M -3.21% | 455.38M | 30.62M | 6.72% |
| Q4 2020 Q2Q % growth | 452.1M | 449.03M | 3.07M | 0.68% |
| Q3 2020 Q2Q % growth | 476.8M | 463.74M | 13.06M | 2.82% |
| Q2 2020 Q2Q % growth | 429.5M | 426.99M | 2.51M | 0.59% |
| Q1 2020 Q2Q % growth | 502.1M | 478.15M | 23.95M | 5.01% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 6.49% | 8.57% | -11.66% | -14.9% |
| Revenue | 0.09% | 0.79% | 0% | 0.03% |